After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID ...

Novavax Inc. jumped after US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...

Only adults 65+ or those with health risks ages 12–64 can get it The vaccine is the only protein-based COVID shot in the U.S.

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...